Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, U4 small nuclear 76, pseudogene (RNU4-76P) is assigned to the category of small nuclear RNA pseudogenes. Unlike functional U4 small nuclear RNAs (snRNAs) such as RNU4-2—which play a critical role in spliceosomal function and pre-mRNA splicing—pseudogenes like RNU4-76P are generally considered non-functional genetic elements that represent noncoding, non-protein-coding sequences derived from ancestral snRNA genes but lacking demonstrated biological activity. There is no established evidence linking RNU4-76P to disease mechanisms, cellular pathways, or drug interactions, and it is not regarded as a therapeutic target[2][3]. If you intended to refer to a functional small nuclear RNA such as U4 snRNA or RNU4-2, please clarify, as RNU4-76P itself does not have a known biological or pharmacological role.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U4 small nuclear 76, pseudogene (RNU4-76P).